Vertex Pharmaceuticals (VRTX) Revenue Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 64.24% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.82% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 19.04% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3,790.58% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.82% |
| Dec 31, 2025 | 9.55% |
| Sep 30, 2025 | 10.99% |
| Jun 30, 2025 | 12.06% |
| Mar 31, 2025 | 2.96% |
| Dec 31, 2024 | 15.66% |
| Sep 30, 2024 | 11.61% |
| Jun 30, 2024 | 6.11% |
| Mar 31, 2024 | 13.30% |
| Dec 31, 2023 | 9.34% |
| Sep 30, 2023 | 6.39% |
| Jun 30, 2023 | 13.52% |
| Mar 31, 2023 | 13.22% |
| Dec 31, 2022 | 11.10% |
| Sep 30, 2022 | 17.65% |
| Jun 30, 2022 | 22.46% |
| Mar 31, 2022 | 21.64% |
| Dec 31, 2021 | 27.32% |
| Sep 30, 2021 | 28.98% |
| Jun 30, 2021 | 17.64% |
| Mar 31, 2021 | 13.81% |
| Dec 31, 2020 | 944.81% |
| Sep 30, 2020 | 61.95% |
| Jun 30, 2020 | 61.96% |
| Mar 31, 2020 | 76.50% |
| Dec 31, 2019 | -82.09% |
| Sep 30, 2019 | 21.07% |
| Jun 30, 2019 | 25.15% |
| Mar 31, 2019 | 33.96% |
| Dec 31, 2018 | 33.53% |
| Sep 30, 2018 | 35.69% |
| Jun 30, 2018 | 38.23% |
| Mar 31, 2018 | -10.34% |
| Dec 31, 2017 | 42.06% |
| Sep 30, 2017 | 41.12% |
| Jun 30, 2017 | 27.84% |
| Mar 31, 2017 | 79.54% |
| Dec 31, 2016 | 12.83% |
| Sep 30, 2016 | 35.43% |
| Jun 30, 2016 | 156.30% |
| Mar 31, 2016 | 204.17% |
| Dec 31, 2015 | 181.24% |
| Sep 30, 2015 | 120.65% |
| Jun 30, 2015 | 35.77% |
| Mar 31, 2015 | 10.49% |
| Dec 31, 2014 | 12.21% |
| Sep 30, 2014 | -38.16% |
| Jun 30, 2014 | -51.99% |
| Mar 31, 2014 | -63.93% |
| Dec 31, 2013 | -61.43% |
| Sep 30, 2013 | -34.02% |
| Jun 30, 2013 | -39.09% |
| Mar 31, 2013 | -12.52% |
| Dec 31, 2012 | -40.71% |
| Sep 30, 2012 | -19.92% |
| Mar 31, 2012 | 409.59% |
| Dec 31, 2011 | 759.75% |
| Sep 30, 2011 | 1,663.37% |
| Mar 31, 2011 | 228.42% |
| Dec 31, 2010 | 93.35% |
| Sep 30, 2010 | -4.66% |
| Jun 30, 2010 | 65.87% |
| Mar 31, 2010 | -6.46% |